We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.16%
AUM
$4.65B
AUM Growth
-$902M
Cap. Flow
-$55.6M
Cap. Flow %
-1.2%
Top 10 Hldgs %
17.2%
Holding
1,576
New
113
Increased
560
Reduced
639
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 16.34%
2 Healthcare 11.48%
3 Financials 11.22%
4 Industrials 8.07%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHO icon
851
Invesco Water Resources ETF
PHO
$2.03B
$605K 0.01%
13,090
+298
+2% +$14.5K
ESBA icon
852
Empire State Realty Series ES
ESBA
$1.34B
$601K 0.01%
84,692
DVA icon
853
DaVita
DVA
$15B
$598K 0.01%
7,474
-1,653
-18% -$167K
TEAF
854
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
$597K 0.01%
43,183
+1,522
+4% +$22.2K
TNDM icon
855
Tandem Diabetes Care
TNDM
$1.38B
$597K 0.01%
10,088
+2,240
+29% +$184K
BND icon
856
Vanguard Total Bond Market
BND
$157B
$594K 0.01%
7,893
+967
+14% +$73.6K
BUD icon
857
AB InBev
BUD
$166B
$592K 0.01%
10,976
-601
-5% -$33.7K
H icon
858
Hyatt Hotels
H
$16.2B
$590K 0.01%
7,984
-86
-1% -$7.46K
CEG icon
859
Constellation Energy
CEG
$97.7B
$587K 0.01%
10,253
-26
-0.3% -$1.56K
STOR
860
DELISTED
STORE Capital Corporation
STOR
$587K 0.01%
22,495
-2,950
-12% -$81.6K
XLG icon
861
Invesco S&P 500 Top 50 ETF
XLG
$10.8B
$586K 0.01%
20,450
-580
-3% -$18.1K
BMEZ icon
862
BlackRock Health Sciences Trust II
BMEZ
$974M
$585K 0.01%
35,577
-1,066
-3% -$18.3K
DON icon
863
WisdomTree US MidCap Dividend Fund
DON
$4.06B
$582K 0.01%
14,919
+774
+5% +$32.6K
BNS icon
864
Scotiabank
BNS
$108B
$581K 0.01%
9,817
+3,152
+47% +$205K
FYX icon
865
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.39B
$579K 0.01%
7,559
JHML icon
866
John Hancock Multifactor Large Cap ETF
JHML
$1.18B
$578K 0.01%
12,124
+672
+6% +$34.8K
ATR icon
867
AptarGroup
ATR
$8.7B
$577K 0.01%
5,592
+310
+6% +$33.8K
TEI
868
Templeton Emerging Markets Income Fund
TEI
$315M
$576K 0.01%
106,891
+1,724
+2% +$10.3K
XOP icon
869
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.68B
$576K 0.01%
4,817
-9,249
-66% -$1.3M
PHYS icon
870
Sprott Physical Gold
PHYS
$14.6B
$573K 0.01%
40,417
-500
-1% -$7.37K
PMO
871
Franklin Municipal Opportunities Trust
PMO
$279M
$573K 0.01%
48,580
+7,000
+17% +$77.4K
BAB icon
872
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
$570K 0.01%
20,547
+1,777
+9% +$49.7K
SLP icon
873
Simulations Plus
SLP
$370M
$570K 0.01%
11,548
-22
-0.2% -$1.04K
JOAN
874
DELISTED
JOANN, Inc. Common Stock
JOAN
$570K 0.01%
73,611
-29,250
-28% -$268K
IWR icon
875
iShares Russell Mid-Cap ETF
IWR
$56.3B
$569K 0.01%
8,802
-3,066
-26% -$218K

Similar funds

Oppenheimer & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Oppenheimer & Co held 1,576 positions worth $4.65B, down 16% from $5.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q2 2022 filing shows 113 new, 560 increased, 639 reduced and 173 closed positions. Its largest new stake was Warner Bros: 379,857 shares worth $5.1M. The largest sale was abrdn Physical Gold Shares ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2022 buy was Warner Bros: 379,857 shares worth $5.1M.
  • Oppenheimer & Co added most to State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2022, an estimated $11.4M increase.
  • Oppenheimer & Co's biggest Q2 2022 reduction was Apple, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited abrdn Physical Gold Shares ETF in Q2 2022, selling an estimated $12.8M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.65B portfolio in Q2 2022.
  • Oppenheimer & Co opened 113 new positions and closed 173 in Q2 2022.
  • Oppenheimer & Co's portfolio value fell 16% quarter-over-quarter to $4.65B.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.